STAT+: TrumpRx adds generic drugs

STAT PlusNewsletterD.C. Diagnosis TrumpRx adds generic drugs You’re reading STAT’s D.C. Diagnosis newsletter Manage alerts for this article Email this article Share this article By John WilkersonMay 19, 2026 Washington Correspondent John Wilkerson[email protected]John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Would you rather get squeaky cheese curds from your MAHA senator or a fake subpoena and Tylenol from your smartalec Kennedy cousin? What I’d like is some news tips at [email protected] or John_Wilkerson.07 on Signal.Advertisement Cassidy lost. Now what? Sen. Bill Cassidy’s (R-La.) primary loss is a win for MAHA, Chelsea Cirruzzo reports, but it’s just one of multiple changes in dynamics that could either make life easier or more difficult for health secretary Robert F. Kennedy Jr. and the Trump administration. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In CMS, Congress, Donald Trump, Drug prices, FDA, HHS, Policy, STAT+, White House Submit a correction requestReprints John Wilkerson Washington Correspondent John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended D.C. Diagnosis May 14, 2026 STAT Plus: The hunt for FDA’s next leader D.C. Diagnosis May 12, 2026 STAT Plus: STAT examines America’s deadliest drug Advertisement D.C. Diagnosis May 7, 2026 STAT Plus: More political interference at the FDA? D.C. Diagnosis May 5, 2026 STAT Plus: A new attack on AMA’s billing codes D.C. Diagnosis April 30, 2026 STAT Plus: Democrats go hard on health care affordability Subscriber Picks